Drug details

Ryaltris (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray)

type of Allergy, Intranasal

Ryaltris (olopatadine hydrochloride and mometasone furoate monohydrate nasal spray) is a combination of a histamine-1 (H1) receptor inhibitor and a corticosteroid used to treat symptoms of seasonal allergic rhinitis in adult and pediatric patients 12 years of age and older. 

The drug is often used to treat Allergic rhinitis .

This drug may have the following side effects:

• severe dizziness
• swelling of your face, lips, tongue, or throat, and
• hives, 
• difficulty breathing, 

The following drugs are related to Ryaltris, either as a replacement or used together:

• Semprex D (acrivastine and pseudoephedrine)
• Allegra (fexofenadine hcl)
• Allegra-D (fexofenadine hcl and pseudoephedrine hcl)
• Allegra-D 24 Hour (fexofenadine hcl 180 and pseudoephendrine hcl 240)
• Clarinex (desloratadine)
• Clarinex-D 12hr (desloratadine and pseudoephedrine sulfate)
• Clarinex-D 24hr (desloratadine and pseudoephedrine sulfate)
• Vistaril (hydroxyzine)
• Zaditor (ketotifen fumarate)
• Xyzal (levocetirizine dihydrochloride)
• Singulair (montelukast sodium)
• Naphcon A (naphazoline hydrochloride and pheniramine maleate solution and drops)
• Nasacort AQ (triamcinolone acetonide)